3D EngNT |
3D-engineered neural tissue |
ADE |
adverse drug event |
ADR |
adverse drug response |
ALC |
acetyl-L-carnitin |
ANOVA |
one-way analysis of variance |
ATCC |
American Type Culture Collection |
BDNF |
brain-derived neurotrophic factor |
Cit |
citicoline |
CNS |
central nervous system |
DMEM-Adv |
Dulbecco’s Modified Eagle’s Medium Advance |
DMEM |
Dulbecco’s Modified Eagle’s Medium |
ELISA |
Enzyme-Linked Immunosorbent Assay |
EMA |
European Medicines Agency |
FBS |
fetal bovine serum |
FDA |
Food and Drug Administration |
G. elata
|
Gastrodia elata Blume extract |
GABA |
γ-aminobutyric acid |
GGF |
glial growth factor 2 |
GLTs |
glucose transporters |
HBA |
p-hydroxy benzyl alcohol |
LA |
lipoic acid |
MEM |
Minimum Essential Medium |
MPZ |
myelin protein zero |
NGF |
nerve growth factor |
NRG1 |
neuregulin 1 |
OS |
oxidative stress |
PN |
peripheral neuropathy |
PNI |
Peripheral Nervous Injury |
PNS |
peripheral nervous system |
RNS |
reactive nitrogen species |
ROS |
reactive oxygen species |
RPMI-Adv |
Roswell Park Memorial Institute-1640 Advanced |
TEER |
transepithelial electrical resistance |
TJ |
tight junction |
Vit. B group |
Vitamin of group B |
ZO-1 |
Zona Occludens 1 |